Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
48.92
-2.45 (-4.77%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Cash & Equivalents | 94.82 | 224.95 | 71.66 | 171.33 | 168.13 | Upgrade
|
| Short-Term Investments | 196.56 | 2.5 | 145.37 | 0.48 | - | Upgrade
|
| Cash & Short-Term Investments | 291.38 | 227.44 | 217.03 | 171.82 | 168.13 | Upgrade
|
| Cash Growth | 28.11% | 4.80% | 26.31% | 2.19% | 190.12% | Upgrade
|
| Accounts Receivable | 46.76 | 16.62 | - | - | - | Upgrade
|
| Other Receivables | 1.3 | 1.09 | 3.58 | 0.09 | 0.02 | Upgrade
|
| Receivables | 48.06 | 17.71 | 3.58 | 0.09 | 0.02 | Upgrade
|
| Inventory | 2.62 | 3.11 | - | - | - | Upgrade
|
| Prepaid Expenses | 14.65 | 7.87 | 4.77 | 4.05 | 2.49 | Upgrade
|
| Restricted Cash | - | - | - | - | 0.02 | Upgrade
|
| Total Current Assets | 356.71 | 256.13 | 225.38 | 175.95 | 170.66 | Upgrade
|
| Property, Plant & Equipment | 2.87 | 3.35 | 1.53 | 1.83 | 1.24 | Upgrade
|
| Long-Term Investments | 3 | 0.86 | 0.48 | 0.66 | - | Upgrade
|
| Other Intangible Assets | 8.33 | 3.87 | - | - | - | Upgrade
|
| Other Long-Term Assets | 6.09 | 1.29 | 0.48 | 0.46 | 0.08 | Upgrade
|
| Total Assets | 376.99 | 265.49 | 227.86 | 178.91 | 171.97 | Upgrade
|
| Accounts Payable | 27.74 | 17.77 | 5.5 | 2.86 | 2.24 | Upgrade
|
| Accrued Expenses | 19.14 | 13.9 | 9.21 | 7.26 | 2.87 | Upgrade
|
| Current Portion of Leases | 0.61 | 0.4 | 0.72 | 0.61 | 0.28 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 0.06 | - | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.7 | - | Upgrade
|
| Other Current Liabilities | 33.12 | 4.87 | - | - | - | Upgrade
|
| Total Current Liabilities | 80.61 | 36.94 | 15.43 | 11.48 | 5.39 | Upgrade
|
| Long-Term Debt | 71.85 | 29.82 | 19.43 | - | - | Upgrade
|
| Long-Term Leases | - | - | - | 0.59 | 0.55 | Upgrade
|
| Other Long-Term Liabilities | - | 1.75 | 0.1 | 0.11 | 0.06 | Upgrade
|
| Total Liabilities | 152.46 | 68.5 | 34.96 | 12.18 | 5.99 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 584.56 | 441.64 | 301.73 | 213.4 | 198.82 | Upgrade
|
| Retained Earnings | -360.21 | -244.66 | -108.76 | -46.67 | -32.85 | Upgrade
|
| Comprehensive Income & Other | 0.18 | -0 | -0.07 | - | - | Upgrade
|
| Total Common Equity | 224.53 | 196.99 | 192.9 | 166.73 | 165.98 | Upgrade
|
| Shareholders' Equity | 224.53 | 196.99 | 192.9 | 166.73 | 165.98 | Upgrade
|
| Total Liabilities & Equity | 376.99 | 265.49 | 227.86 | 178.91 | 171.97 | Upgrade
|
| Total Debt | 72.45 | 30.22 | 20.16 | 1.19 | 0.83 | Upgrade
|
| Net Cash (Debt) | 218.92 | 197.23 | 196.87 | 170.62 | 167.3 | Upgrade
|
| Net Cash Growth | 11.00% | 0.18% | 15.38% | 1.99% | 189.50% | Upgrade
|
| Net Cash Per Share | 5.82 | 6.71 | 8.00 | 8.30 | 26.95 | Upgrade
|
| Filing Date Shares Outstanding | 38.38 | 34.22 | 26.73 | 20.71 | 20.32 | Upgrade
|
| Total Common Shares Outstanding | 38.35 | 34.21 | 26.73 | 20.7 | 20.32 | Upgrade
|
| Working Capital | 276.09 | 219.2 | 209.95 | 164.47 | 165.27 | Upgrade
|
| Book Value Per Share | 5.85 | 5.76 | 7.22 | 8.06 | 8.17 | Upgrade
|
| Tangible Book Value | 216.21 | 193.12 | 192.9 | 166.73 | 165.98 | Upgrade
|
| Tangible Book Value Per Share | 5.64 | 5.64 | 7.22 | 8.06 | 8.17 | Upgrade
|
| Machinery | 3.5 | 2.08 | 1.08 | 0.85 | 0.54 | Upgrade
|
| Leasehold Improvements | 0.79 | 0.68 | 0.43 | 0.13 | 0.14 | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.